Ligand Pharmaceuticals Incorporated (LGND) — Capital Reinvestment Ratio
Ligand Pharmaceuticals Incorporated (LGND) has a Capital Reinvestment Ratio of 0.00x as of March 2026, meaning it reinvests 0% of its operating cash flow ($48.69 Million) in capital expenditures ($228.00K). See LGND net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Ligand Pharmaceuticals Incorporated Capital Reinvestment Ratio (2003–2025)
This chart tracks Ligand Pharmaceuticals Incorporated's Capital Reinvestment Ratio across 16 annual periods. Check Ligand Pharmaceuticals Incorporated cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Ligand Pharmaceuticals Incorporated (2003–2025)
Year-by-year Capital Reinvestment Ratio for Ligand Pharmaceuticals Incorporated from 2003 to 2025. For live market cap and broader valuation context, see LGND stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.01x | $49.36 Million | $452.00K | ▼ -95.5% |
| 2024 | 0.20x | $97.05 Million | $19.64 Million | ▼ -81.4% |
| 2023 | 1.09x | $49.58 Million | $53.85 Million | ▲ +735.4% |
| 2022 | 0.13x | $137.85 Million | $17.92 Million | ▲ +16.9% |
| 2021 | 0.11x | $78.80 Million | $8.76 Million | ▲ +36.1% |
| 2020 | 0.08x | $54.59 Million | $4.46 Million | ▲ +33.3% |
| 2018 | 0.06x | $194.06 Million | $11.89 Million | ▼ -19.9% |
| 2017 | 0.08x | $93.57 Million | $7.15 Million | ▼ -83.0% |
| 2016 | 0.45x | $63.00 Million | $28.32 Million | ▲ +72.7% |
| 2015 | 0.26x | $41.73 Million | $10.86 Million | ▲ +19.0% |
| 2014 | 0.22x | $20.57 Million | $4.50 Million | ▼ -8.3% |
| 2013 | 0.24x | $20.69 Million | $4.94 Million | ▼ -99.6% |
| 2012 | 53.69x | $161.00K | $8.64 Million | ▲ +1161.7% |
| 2005 | 4.26x | $8.37 Million | $35.60 Million | ▲ +579.4% |
| 2004 | 0.63x | $5.75 Million | $3.60 Million | ▼ -93.8% |
| 2003 | 10.16x | $274.00K | $2.78 Million | — |